Synopsis

Source of validity: Traditional
Rating (out of 5): 2

Bioflavonoids, a group of plant-derived compounds with antioxidant properties, have a long history of traditional use to support vascular health, including eye health. Their application in diabetic retinopathy is rooted more in traditional and empirical practice than in robust scientific validation. Historically, bioflavonoids (such as rutin, quercetin, and hesperidin) have been believed to strengthen capillaries and reduce vascular permeability, which is relevant in diabetic retinopathy—a condition characterized by damage to the retinal microvasculature due to chronic hyperglycemia. Some early studies and traditional medical practices suggested that bioflavonoids could help reduce capillary fragility and hemorrhage in diabetic patients. However, while there is a plausible biochemical rationale (antioxidant and anti-inflammatory properties, and possible inhibition of aldose reductase), high-quality clinical trials directly demonstrating efficacy in preventing or treating diabetic retinopathy are limited. A few small studies and animal models have indicated potential benefit, but systematic reviews and meta-analyses do not provide strong support for their widespread use in this context. Major diabetes and ophthalmology guidelines do not recommend bioflavonoids as a standard therapy for diabetic retinopathy. In summary, the use of bioflavonoids for diabetic retinopathy persists largely due to traditional beliefs and limited preliminary research, rather than solid scientific validation.

More about Bioflavonoids (mixture)
More about Diabetic Retinopathy

Other ingredients used for Diabetic Retinopathy

Other health conditions supported by Bioflavonoids (mixture)

Products containing Bioflavonoids (mixture)